Regeneron Pharmaceuticals, Inc. logo

Regeneron Pharmaceuticals, Inc. (REGN)

Market Closed
2 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
547. 74
+12.83
+2.4%
$
55.3B Market Cap
24.52 P/E Ratio
0% Div Yield
817,481 Volume
42.79 Eps
$ 534.91
Previous Close
Day Range
529.69 551.5
Year Range
476.49 1,211.2
Want to track REGN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 27 days
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
30 Jul 2025 (In 3 weeks)
8.53
Cons. EPS
-
EPS
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
30 Apr 2025
-
Cons. EPS
-
EPS
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
31 Jan 2025
11.38
Cons. EPS
12.07
EPS
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
31 Oct 2024
11.69
Cons. EPS
12.46
EPS
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
1 Aug 2024
10.61
Cons. EPS
11.56
EPS
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
2 May 2024
10.09
Cons. EPS
9.55
EPS
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
2 Feb 2024
10.73
Cons. EPS
11.86
EPS
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
2 Nov 2023
10.72
Cons. EPS
11.59
EPS
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
4 Nov 2016
2.71
Cons. EPS
3.13
EPS
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
4 Aug 2016
2.65
Cons. EPS
2.82
EPS
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
5 May 2016
2.58
Cons. EPS
2.57
EPS
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
9 Feb 2016
3.36
Cons. EPS
2.83
EPS
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
4 Nov 2015
3.2
Cons. EPS
3.47
EPS
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
4 Aug 2015
2.77
Cons. EPS
2.89
EPS
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
7 May 2015
2.68
Cons. EPS
2.88
EPS
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
10 Feb 2015
2.82
Cons. EPS
2.79
EPS
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
4 Nov 2014
2.57
Cons. EPS
2.52
EPS
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
5 Aug 2014
2.29
Cons. EPS
2.47
EPS
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
8 May 2014
2.2
Cons. EPS
2.26
EPS
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
11 Feb 2014
0.98
Cons. EPS
0.86
EPS
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
5 Nov 2013
0.9
Cons. EPS
1.25
EPS
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
6 Aug 2013
0.88
Cons. EPS
0.79
EPS
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
3 May 2013
0.98
Cons. EPS
0.9
EPS
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
14 Feb 2013
1.1
Cons. EPS
1.22
EPS

REGN Earnings Reports FAQ

What is the earnings per share (EPS) for REGN?

The current EPS is 42.79.

What is the company's earnings growth rate?

Over the past 12 years, the earnings growth rate has been approximately 23.16%, reflecting the REGN's performance and NASDAQ (NGS) market conditions.

When is the next earnings release date?

The next earnings release is expected to be on 2025-07-30, based on the REGN's typical earnings announcement schedule.